BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25239119)

  • 1. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.
    Li P; Wu H; Zhang H; Shi Y; Xu J; Ye Y; Xia D; Yang J; Cai J; Wu Y
    Gut; 2015 Sep; 64(9):1419-25. PubMed ID: 25239119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
    BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
    Domingo E; Church DN; Sieber O; Ramamoorthy R; Yanagisawa Y; Johnstone E; Davidson B; Kerr DJ; Tomlinson IP; Midgley R
    J Clin Oncol; 2013 Dec; 31(34):4297-305. PubMed ID: 24062397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
    Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.
    Kothari N; Kim R; Jorissen RN; Desai J; Tie J; Wong HL; Faragher I; Jones I; Day FL; Li S; Sakthinandeswaren A; Palmieri M; Lipton L; Schell M; Teer JK; Shibata D; Yeatman T; Sieber OM; Gibbs P; Tran B
    Acta Oncol; 2015 Apr; 54(4):487-92. PubMed ID: 25549537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
    Paleari L; Puntoni M; Clavarezza M; DeCensi M; Cuzick J; DeCensi A
    Clin Oncol (R Coll Radiol); 2016 May; 28(5):317-26. PubMed ID: 26712086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies.
    Ye XF; Wang J; Shi WT; He J
    Br J Cancer; 2014 Nov; 111(11):2172-9. PubMed ID: 25180765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ling Y; Yang L; Huang H; Hu X; Zhao C; Huang H; Ying Y
    Medicine (Baltimore); 2015 Jun; 94(25):e908. PubMed ID: 26107680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin use and risk of colorectal cancer according to BRAF mutation status.
    Nishihara R; Lochhead P; Kuchiba A; Jung S; Yamauchi M; Liao X; Imamura Y; Qian ZR; Morikawa T; Wang M; Spiegelman D; Cho E; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    JAMA; 2013 Jun; 309(24):2563-71. PubMed ID: 23800934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
    J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.
    Zell JA; Ziogas A; Bernstein L; Clarke CA; Deapen D; Largent JA; Neuhausen SL; Stram DO; Ursin G; Anton-Culver H
    Cancer; 2009 Dec; 115(24):5662-71. PubMed ID: 19827153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
    Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
    J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.
    Walker AJ; Grainge MJ; Card TR
    Br J Cancer; 2012 Oct; 107(9):1602-7. PubMed ID: 23011483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin use and survival after diagnosis of colorectal cancer.
    Chan AT; Ogino S; Fuchs CS
    JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.
    Reimers MS; Bastiaannet E; Langley RE; van Eijk R; van Vlierberghe RL; Lemmens VE; van Herk-Sukel MP; van Wezel T; Fodde R; Kuppen PJ; Morreau H; van de Velde CJ; Liefers GJ
    JAMA Intern Med; 2014 May; 174(5):732-9. PubMed ID: 24687028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biomarker for aspirin use in colorectal cancer therapy.
    Langley RE; Rothwell PM
    Nat Rev Clin Oncol; 2013 Jan; 10(1):8-10. PubMed ID: 23207797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.
    Kunzmann AT; Murray LJ; Cardwell CR; McShane CM; McMenamin UC; Cantwell MM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1490-7. PubMed ID: 23810915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis.
    Figueiredo JC; Jacobs EJ; Newton CC; Guinter MA; Cance WG; Campbell PT
    J Natl Cancer Inst; 2021 Jul; 113(7):833-840. PubMed ID: 33528005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
    Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
    Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
    Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
    Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.